| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/02/2007 | EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators |
| 05/02/2007 | EP1778615A2 Oligomeric ketone compounds |
| 05/02/2007 | EP1778359A1 Pharmaceutical compositions for alleviating excess levels of sugar in diabetic patients |
| 05/02/2007 | EP1778274A2 Modulation of fiaf and the gastrointestinal microbiota |
| 05/02/2007 | EP1778261A2 Compositions and methods for treatment and prevention of insulin resistance |
| 05/02/2007 | EP1778250A2 Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
| 05/02/2007 | EP1778225A2 Pyrrolo(oxo)isoquinolines as 5ht ligands |
| 05/02/2007 | EP1778218A1 Cholesterol lowering supplement and low cholesterol egg produced by using the same |
| 05/02/2007 | EP1687014B1 Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 05/02/2007 | EP1482919B1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | EP0934352B1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 05/02/2007 | EP0725648B1 Hepatoselective pharmaceutical actives |
| 05/02/2007 | CN1957082A Novel galectin 9 modification protein and use thereof |
| 05/02/2007 | CN1956984A 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 05/02/2007 | CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics |
| 05/02/2007 | CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/02/2007 | CN1956728A Enzymes for pharmaceutical use |
| 05/02/2007 | CN1956719A Specific ppar excitant for treating negative energy equilibrium |
| 05/02/2007 | CN1956713A Agent for preventing/amelioration life style-related diseases containing turmeric essential oil component |
| 05/02/2007 | CN1956711A Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same |
| 05/02/2007 | CN1955182A Purine compound and use as cannabinoid receptor ligands |
| 05/02/2007 | CN1955181A Purine compound and use as cannabinoid receptor ligands |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955179A [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1954835A Sea-buckthorn plant preparation and its preparation method |
| 05/02/2007 | CN1954826A Use of ginkgo biloba extract in cholesterol reducing |
| 05/02/2007 | CN1954825A Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 05/02/2007 | CN1954817A Preparation method of injection type pH and glucose sensitive hydrogel |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313600C Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
| 05/02/2007 | CN1313492C B-chain modified monomer quick-acting insulin and method for preparing same |
| 05/02/2007 | CN1313475C Use of polygonum cuspidatum tannic acid of polygonum cuspidatum extract in the preparation of medicine for lowering blood sugar and treating diabetes |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313126C Medicine composition for treating hyperlipemia and its preparing method |
| 05/02/2007 | CN1313113C 'Wudan Xinggan' granular for treating fatty liver, and its prepn. method |
| 05/02/2007 | CN1313097C Baby preparation containing free amino-acid and nucleotide |
| 05/02/2007 | CN1313091C Vitamin C composition |
| 05/02/2007 | CN1313090C Aotomatic controlling nurve regulator and its health drinks and foods |
| 05/02/2007 | CN1313089C Stimulation of CPT-1 as a means to reduce weight |
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | CN1313080C Improved water-insoluble drug particle preparing process |
| 05/02/2007 | CN1313030C Novel nutraceutical compositions comprising biotin |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells |
| 05/01/2007 | US7211662 Soluble highly branched glucose polymers and their method of production |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211592 Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211571 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211283 Casing of a gelatin-free, water- based, set hydrocolloid gel that forms an enclosure, and at least one solid, liquid, soft or particulate center enclosed by the casing |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211248 Controlling lipid metabolism; injecting a solution of Dna, Rna gene using gas microbubbles using ultrasonic frequency; gene expression |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2138675C Catecholamine surrogates useful as .beta.3 agonists |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047725A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | WO2007047724A2 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | WO2007047722A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | WO2007047676A1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007047596A1 Methods for reducing food intake and decreasing appetite in animals |
| 04/26/2007 | WO2007047432A1 Sulfonamide derivatives as modulators of ppar |
| 04/26/2007 | WO2007047401A2 A1 adenosine receptor agonists |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007047112A2 Anti-myostatin antibodies |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007045393A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045392A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007017145A3 Gsk-3 inhibitors |
| 04/26/2007 | WO2007017067A3 Modulators of the melted protein and uses thereof |
| 04/26/2007 | WO2007009683A3 Pharmaceutical formulations of substituted pyrazoline compounds |
| 04/26/2007 | WO2006117307B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 04/26/2007 | WO2005012304A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 04/26/2007 | US20070093553 HMB compositions and uses thereof |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |